目前和新兴的耳免疫抑制方法与转化到人类内耳干细胞疗法:系统性审查
Nathan J Creber1,2, Jameel Muzaffar1, Shravan Gowrishankar1
1Cambridge University Hospitals NHS Trust, United Kingdom.
PloS one
|February 13, 2025
概括
内耳干细胞疗法对听力损失有希望,但面临免疫排斥. 了解内耳免疫力对于成功的干细胞治疗和减少听力损伤至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 再生医学是一种再生医学.
背景情况:
- 感官神经听力损失影响全球数以百万计的人,通常是由于神经感官损伤.
- 内耳干细胞治疗提供了一种再生方法,将重点从修复转向再生.
- 目前,宿主免疫反应限制了内耳中供体干细胞的有效性.
研究的目的:
- 审查当前对内耳免疫系统的理解.
- 在内耳病理和当前药物治疗中探索免疫失调.
- 系统地评估内耳干细胞治疗的免疫抑制策略.
主要方法:
- 系统性文献综述,重点关注内耳病理的免疫抑制.
- 在内耳干细胞治疗的翻译模型中对免疫抑制剂的评估.
- 对干细胞适应的当代免疫抑制疗法的分析.
主要成果:
- 免疫失调有助于内耳病理.
- 药物治疗可以通过免疫抑制来减轻末端器官损伤.
- 有证据表明,免疫抑制剂可能有助于干细胞在耳和听觉神经中融合.
结论:
- 更深入地了解内耳免疫力对于推进干细胞疗法至关重要.
- 免疫抑制策略是克服捐赠细胞免疫排斥的关键.
- 优化的免疫抑制疗法可以使听力损失的干细胞治疗成功.
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:17Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K